Concepedia

Christopher S. Kearn

CS

9

Publications

1.4K

Citations

9

H-Index

1998

Active since

Affiliations

University of Washington(Current)

Medical College of Wisconsin

University of Auckland

Christopher S. Kearn is an author at University of Washington specializing in medicine, pharmacology, and obstetrics.

Top concepts

Publications per year

1998–2008

9

Publications

9

Concurrent Stimulation of Cannabinoid CB1 and Dopamine D2 Receptors Enhances Heterodimer Formation: A Mechanism for Receptor Cross-Talk?

Christopher S. Kearn, Katherine G. Blake-Palmer, Emma Daniel et al. · Molecular Pharmacology · 2005 · 351 citations

Cultured Rat Microglial Cells Synthesize the Endocannabinoid 2-Arachidonylglycerol, Which Increases Proliferation via a CB2 Receptor-Dependent Mechanism

Erica J. Carrier, Christopher S. Kearn, Andrew J. Barkmeier et al. · Molecular Pharmacology · 2004 · 331 citations

Rapid CB1 cannabinoid receptor desensitization defines the time course of ERK1/2 MAP kinase signaling

Tanya L. Daigle, Christopher S. Kearn, Ken Mackie · Neuropharmacology · 2007 · 146 citations · Full text

, , +10

Targeting dopamine D2 and cannabinoid‐1 (CB1) receptors in rat nucleus accumbens

Virgina M. Pickel, Jane W. Chan, Christopher S. Kearn et al. · The Journal of Comparative Neurology · 2006 · 125 citations · Full text

Relationships Between Ligand Affinities for the Cerebellar Cannabinoid Receptor CB1 and the Induction of GDP/GTP Exchange

Christopher S. Kearn, Marcie J. Greenberg, Ralph F. DiCamelli et al. · Journal of Neurochemistry · 1999 · 122 citations

Rows per page

1–5 of 9